Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Transplanted Muscle Cells May Aid Damaged Hearts

By Biotechdaily staff writers
Posted on 28 Nov 2002
A study in which muscle cells were transplanted from the thighs of heart patients into their damaged hearts shows evidence of skeletal muscle cell survival and differentiation into mature muscle fibers, leading perhaps to a way to repair damaged hearts without rejection. More...
The results were presented at the 2002 Scientific Sessions of the American Heart Association in Chicago, IL (USA).

Three patients had cells from their thigh muscles injected into their heart muscle while they awaited a heart transplant, then allowed their old, damaged hearts to be examined for signs of cell growth after they received a new heart. Examination revealed that the injected cells not only survived but also began to form muscle fiber. In addition, the areas where the cells were injected showed an increase in the formation of small blood vessels. Since the muscle cells came from the patients' own bodies, none of the patients experienced an immune reaction to the transplants.

The study is based on the premise that certain kinds of cells can be expanded in culture and maintain their functional characteristics. Instead of stem cells, the study used satellite cells, which occur naturally in muscle and help repair damage by dividing and moving to injured areas. After removing cells from the quadriceps muscle, researchers treated them with enzymes to isolate the satellite cells. These were then grown in a laboratory under carefully controlled conditions to give the cells time to divide and produce 300 million cells.

One arm of the study was conducted at the University of Michigan Health System (U-M, Ann Arbor, USA) and Temple University (Chattanooga, TN, USA). This arm involved patients awaiting a heart transplant or a left ventricular assist device (LVAD). Another arm of the study, conducted at the Arizona Heart Institute (Phoenix, USA; www.azheart.com), examined how well patients tolerated different doses of transplanted muscles cells during heart bypass surgery. Indirect evidence of scar tissue regeneration was noted in these patients.

"These results give us the first indication that muscle cell transplants, even from an entirely different kind of muscle, could one day be used to help repair damaged, failing hearts without danger of rejection,” said Francis Pagani, M.D., Ph.D., head of the heart transplant program at the U-M Cardiovascular Center.




Related Links:
Univ. of Michigan
Temple Univ

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.